A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- A. Lyberopoulou, E.P. Efstathopoulos, M. Gazouli, Nanodiagnostic and Nanotherapeutic Molecular Platforms for Cancer Management , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Khosravi-Shahi Parham, Aparicio-Salcedo María Inmaculada, Alva-Bianchi Manuel, Arregui-Valles Marta, Morón-García Blanca Isabel, Tirado-Anula Victoria Clara, De Toro-Carmena María, Martínez-Delfrade Iñigo, González-del-Val Ricardo, Liver Abscesses in Cancer Patients Associated with Poor Prognosis: A Single Center Experience , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Gregory Loewen, Ying Zhuo, Yan Zhuang, Janarthanan Jayawickramarajahand, Bin Shan, lincRNA HOTAIR as a Novel Promoter of Cancer Progression , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Herve Kada Pabame, Armel Herve Nwabo Kamdje, Richard Tagne Simo, Franklin Danki Sillong, Study of the Prevalence and the Incidence of the Prostate Cancer in the North-Cameroon: Means and Costs of Management , Journal of Cancer Research Updates: Vol. 7 No. 2 (2018)
- Zahraa A.G. Al Ghuraibawi, Evaluation of Interleukin-8 (IL-8) Levels before and after Radiotherapy in Thyroid Carcinoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Zheng Fang, Du Lianfang, Xie Cuiqi, Shao Shaowei, Luo Qiaoming, Li Qiyan, Ma Ling, A Prospective Study on the Application of Endometrial Cytology Examination in the Screening of Endometrial Cancer , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Marcos F. Dall’Oglio, Alexandre Crippa, Jose Roberto Colombo Junior, Rafael F. Coelho, Eder Nisi Ilário, Miguel Srougi, Nephron-Sparing Surgery in Renal Cell Carcinoma: Morbidity and Outcomes , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- M. Shankar Ganesh, R. Revanth, C. Mahesh Elaya Bharathi, Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence , Journal of Cancer Research Updates: Vol. 14 (2025)
- Francesco Ziglioli, Umberto Maestroni, The Oncological Outcome of HIFU for the Treatment of Localized Prostate Cancer , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Hua-Qing Chen, Yi-Si Li, Si-Chao Huang, Ya-Hua Lin, Qiu-Tong Tan, Shu-Ting Ao, Jun Xu, Shao-Hui Cai, The Clinical Efficacy and Safety of Paclitaxel in Adjuvant Therapy of Breast Cancer: A Systematic Review and Meta-Analysis , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)